WebJun 29, 2024 · CAMBRIDGE, Mass., June 29, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics(Nasdaq: CERE), a company dedicated to unraveling the mysteries of the … WebJun 15, 2024 · CAMBRIDGE, Mass., June 15, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CVL-871, a D1/D5 partial agonist in …

Press Release Details - investors.cerevel.com

WebSep 30, 2024 · Cerevel is conducting two adequately-powered placebo-controlled Phase 2 trials, known as EMPOWER-1 and EMPOWER-2. Data for both trials are expected in the first half of 2024. ... This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to … WebApr 11, 2024 · CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced it will report first quarter 2024 financial results and business updates on Wednesday, May 3, 2024, before the U.S. … did john elway get fired

Cerevel Therapeutics to Report First Quarter 2024 Financial …

WebDec 19, 2024 · CAMBRIDGE, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the … WebApr 13, 2024 · “Cerevel continues its track record of innovative deal making with today’s announcement, a strategic funding arrangement to support the completion of the full Phase 3 development program for tavapadon in Parkinson’s disease,” said Tony Coles, chairperson and chief executive officer of Cerevel Therapeutics. ... This press release ... did john ericson play the piano in rhapsody